Central Laboratory Testing

CLINICAL TRIALS BIOMARKER TESTING

Detection covers targets including MET, HER2, EZH2, MRD, Claudin18.2, MTAP, IDH1/2, EGFR, KRAS, NTRK, FGFR, etc.